Background: Serum LDH levels can be used to assess the extent of cellular death and thereby the severity of disease in this group of women. This will help in making decision, about the management guidelines to the better the maternal and fetal outcome. Objective of present study was compare serum LDH levels in the normal pregnant women and in women with preeclampsia and eclampsia in ante-partum period and to study the association of maternal and perinatal outcomes with serum LDH levels. Methods: It is a prospective study done at Obstetrics and Gynecology department, GMERS medical college and civil hospital, Gandhinagar during August-September 2016. Participants were divided into four groups according to severity of disease and into three groups according to serum LDH level. Results: Mean level of LDH (IU/l) in Control, Mild pre-eclampsia, Severe pre-eclampsia & Eclampsia was 302. 33, 398.56, 675.26 & 1589.85 respectively. Out of total 34 cases with LDH level >800 IU/L, 47.1% cases had ≥160 mm hg SBP & 52.9% had ≥110 mm hg DBP, mean gestational age and mean baby weight was 36.88 week and 1950 gm, mean apgar score at 10 min was 6.96, 47.1% had uneventful outcome, whereas 58.8% had neonatal complications and 5.9% had neonatal death. Almost 26.5% still births, 47.1% perinatal deaths. Conclusions: Higher serum LDH levels during pregnancy have significant association with severity of disease and maternal and fetal outcomes in patients of preeclampsia and eclampsia and can be considered as a supportive prognostic tool from early third trimester.
INTRODUCTION
Preeclampsia, concern with high blood pressure (BP ≥140/90 mmHg) and increased mother's urinary protein (urinary albumin protein ≥ 300 mg/24 h) is a dangerous complication of pregnancy, condition that typically begins after 20th week of pregnancy. 1, 2 Pre-eclampsia is ranging from mild to severe form and is a reason of maternal and neonatal mortality and morbidity. 3, 4 Prevalence of pre-eclampsia in World, India and Gujarat was 4.0%, 8% to 10% and 35.3% respectively. These are multisystem disorders and lead to a lot of cellular death. [4] [5] [6] Level of intra-cellular Lactate Dehydrogenase (LDH) increased in the women due to pre-eclampsia because of cellular death. So, serum LDH levels can be used to assess the extent of cellular death and thereby the severity of disease in this group of women. This will help in making decision, about the management guidelines for better maternal and fetal outcome. 7 Objectives of present study were to compare serum LDH levels in the normal pregnant women and in women with preeclampsia and eclampsia in ante-partum period and to study the association of maternal and perinatal outcomes with serum LDH levels.
METHODS
This was a prospective study done at Obstetrics and Gynecology department, GMERS medical college and civil hospital, Gandhinagar during August-September 2016 after taking permission from Institutional Ethical Committee (IEC) of GMERS Medical College, Gandhinagar. Study enrolled 102 pregnant women who attended OPD at Obstetrics and Gynecology department after obtaining written consent.
A sample size of 102 is obtained by using the hypothesis testing method and based on following assumptions: 95% confidence intervals, prevalence of pre-eclampsia in Gujarat6 35.3% and 5% margin of error. The calculated minimum sample has been inflated by 10% to account for anticipated subject non response.
Present study was enrolled women in third trimester of pregnancy and divided them into four groups.
• Group 1 Third trimester healthy pregnant women (n= 28) • Group 2 Third trimester pregnant women who has mild pre-eclampsia (n=30) • Group 3 Third trimester pregnant women who has severe pre-eclampsia (n=22) • Group 4 Third trimester pregnant women who has eclampsia (n=22)
Participants was also divided according to the serum LDH level into following groups:
• A <600 IU/L • B 600-800 IU/l • C >800 IU/L Exclusion Criteria of present study was mothers with hypertension with <20 weeks gestation; Preexisting diabetes mellitus, renal disease, liver disorder, thyroid disorder, epilepsy.
Outcome of the study was LDH level, Gestational age, baby weight, APGAR score, Maternal complication (eclampsia, abruptio placenta, intracranial heamorrhage etc.) neonatal complications, neonatal death, still birth, perinatal death, maternal vitals.
Variable
• Mild pre-eclampsia: Onset of hypertension after 20 weeks of gestation with diastolic blood pressure (DBP) >90 and ≤110 mmHg with or without proteinuria. • Severe pre-eclampsia: DBP >110 mmHg was measured on two occasions 6 hours apart with significant proteinuria (>500 mg/24 h).
RESULTS
Around 27.4% pregnant women have normal blood pressure. Almost 29.4%, 21.6% and 21.6% cases were belonged to mild pre-eclampsia, severe pre-eclampsia and eclampsia category respectively.
All the participants of were belonged to the age group of 21-30 year but the difference between mean age among all category was statistically not significant (p>0.05). Distribution according to parity was similar in both groups and also statistically significant (p<0.05) ( Table  1) . Mean apgar score at 1 min was 6.15 in cases with LDH level <600 IU/l, 6.85 in cases with LDH level 600-800 IU/l, 4.52 in cases with LDH level >800 IU/l respectively. Mean apgar score at 10 min was 7.97 in cases with LDH level <600 IU/l, 7.89 in cases with LDH level 600-800 IU/l, 6.96 in cases with LDH level >800 IU/l respectively. Difference in mean apgar score at 1, 5 and 10 minutes among all groups was statistically significant (p<0.05) ( Table 4 ).
When LDH levels were normal (57 cases), 84.2% cases had an uneventful perinatal period. 22.8% had neonatal complications, while 5.3% neonatal deaths were reported and there were two cases (3.6%) of still births, i.e., there were 21.1% perinatal deaths.
In the women with LDH levels in the range of 600-800 IU/l (11 cases), 54.5% had uneventful outcome, while 45.5% had neonatal death and 36.4% had neonatal complications. In this group 27.3% still births were present i.e., there were 54.5% perinatal deaths. In the third group where LDH levels were more elevated there were 34 cases out of which only 47.1% had uneventful outcome, whereas 58.8% had neonatal complications and 5.9% had neonatal death. Almost 26.5% still births were reported, i.e., there were 47.1% perinatal deaths. And the occurrence of different perinatal outcomes among all groups was statistically significance (p<0.05) ( Table 4 ).
DISCUSSION
Preeclampsia is an idiopathic multisystem disorder, that is specific to human pregnancy and the prevention of it major impact on decreasing maternal and perinatal morbidity and mortality.
Present study, LDH has been evaluated as a biochemical marker for the prediction of complications of preeclampsia and eclampsia.
In present study, all the participants were belonged to younger age group (p<0.05) and most of were nalliparous (p<0.05 
CONCLUSION
Higher serum LDH levels during pregnancy have significant association with severity of disease and maternal and fetal outcomes in patients of preeclampsia and eclampsia and can be considered as a supportive prognostic tool from early third trimester.
